Last update 23 Jan 2025
Nitto Avecia Pharma Services, Inc.

Nitto Avecia Pharma Services, Inc.

Subsidiary Company|
1988|
California, United States
|
100-250
|
www.aveciapharma.com

Overview

Tags

Infectious Diseases
Respiratory Diseases
Otorhinolaryngologic Diseases
Fusion protein
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Endocrinology and Metabolic Disease1
Immune System Diseases1
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Fusion protein1
Top 5 TargetCount
GR(Glucocorticoid receptor)1
sialic acid1

Related

2
Drugs associated with Nitto Avecia Pharma Services, Inc.
Triamcinolone Acetonide
Target
GR
Mechanism
GR agonists
Active Org.
Apothecon LLC [+16]
Originator Org.
Apothecon BV
Active Indication
Uveitic Macular Edema [+75]
Inactive Indication
Age Related Macular Degeneration [+13]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date04 Jan 1960
oplunofusp
Target
sialic acid
Mechanism
sialic acid inhibitors [+1]
Active Org.
Ansun Biopharma, Inc.Ansun Biopharma, Inc. [+2]
Originator Org.
Ansun Biopharma, Inc.Ansun Biopharma, Inc.
Active Indication
COVID-19 [+3]
Inactive Indication
Asthma [+4]
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Nitto Avecia Pharma Services, Inc.
CTR20200279
/ Not yet recruitingPhase 2
为考察DAS181用于治疗重症流感感染的疗效和安全性而开展的一项IIb期、随机化、安慰剂对照研究
[Translation] A Phase IIb, randomized, placebo-controlled study to investigate the efficacy and safety of DAS181 in the treatment of severe influenza infection
CTR20210106
/ Active, not recruitingPhase 3
一项评估曲安奈德脉络膜上腔注射混悬液（ARVN001）治疗继发于非感染性葡萄膜炎的黄斑水肿的有效性和安全性的随机、双盲、假注射对照、多中心III期研究
[Translation] A randomized, double-blind, sham-controlled, multicenter phase III study to evaluate the efficacy and safety of triamcinolone acetonide suprachoroidal injection suspension (ARVN001) in the treatment of macular edema secondary to non-infectious uveitis
100 Clinical Results associated with Nitto Avecia Pharma Services, Inc.
Login to view more data
0 Patents (Medical) associated with Nitto Avecia Pharma Services, Inc.
Login to view more data
100 Deals associated with Nitto Avecia Pharma Services, Inc.
Login to view more data
100 Translational Medicine associated with Nitto Avecia Pharma Services, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Phase 3 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Triamcinolone Acetonide
 ( GR )		-
Phase 3
oplunofusp
 ( sialic acid )		Influenza, Human
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free